Rapid Screening of Anticoagulation Compounds for Biological Target-Associated Adverse Effects Using a Deep-Learning Framework in the Management of Atrial Fibrillation. [PDF]
Dong T +3 more
europepmc +1 more source
Vitamin K Antagonists (VKAs) and Novel Oral Anticoagulants (NOACs) Safety Comparison Based on Data from EudraVigilance Database. [PDF]
Olimpieri PP +14 more
europepmc +1 more source
Nordic mcl2-3 trials: mirna-18b overexpression identifies a mantle cell lymphoma subgroup with poor survival and improves mipi-b prediction of prognosis [PDF]
Brown, P. D. N. +16 more
core
Direct oral anticoagulants in very elderly and high-bleeding-risk patients with atrial fibrillation often excluded from oral anticoagulation therapy: a nationwide population-based cohort study. [PDF]
Go YH +7 more
europepmc +1 more source
A case of anticoagulation-related nephropathy complicated by IgA nephropathy that developed following the long-term use of anticoagulants. [PDF]
Oyama Y +4 more
europepmc +1 more source
Current clinical research status and future treatment directions for liver cirrhosis combined with portal vein thrombosis. [PDF]
He WL, Yan S, Lu JJ, Chen L, Wu JZ.
europepmc +1 more source
Predictors of hematoma expansion in intracerebral hemorrhage associated with factor Xa inhibitors. [PDF]
Komatsu Y +6 more
europepmc +1 more source
The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease [PDF]
et al, +2 more
core +1 more source
Anticoagulation in Frail Older Adults with Non-Valvular Atrial Fibrillation: Clinical Challenges and Personalized Approach. [PDF]
Fabbri E, Maestri L, Muratori P.
europepmc +1 more source

